ASTRAZENECA PLC
AZNCFDrugs in Pipeline
262
Phase 3 Programs
169
Upcoming Catalysts
16
Next Catalyst
Apr 30, 2026
12dMarket Overview
Stock performance and key metrics
16 upcoming, 1 past
Tozorakimab Phase 2 Results Expected
Primary completion for Tozorakimab trial (NCT06897748) in Chronic Obstructive Pulmonary Disease (COPD)
SourceAZD7798 Phase 2 Results Expected
Primary completion for AZD7798 trial (NCT06450197) in Moderate to Severe Crohn's Disease
Source14 more catalysts beyond 14 days
Start a 48h free trial to see all upcoming catalysts
budesonide (Pulmicort)
Chronic Obstructive Pulmonary Disease
SEROQUEL (quetiapine fumarate) Tablets
Bipolar Disorder
Carboplatin
Endometrial Cancer
Tozorakimab
Asthma
Taxane
Breast Cancer; HER2-positive; Metastatic
Metformin XR
Type 2 Diabetes
AZD0486
B-cell Acute Lymphoblastic Leukemia (B-ALL)
methotrexate
Squamous Cell Carcinoma of the Head and Neck
Rosuvastatin 20mg
Homozygous Familial Hypercholesterolemia (HoFH)
Aclidinium bromide
Chronic Obstructive Pulmonary Disease
Aclidinium Bromide/Formoterol Fumarate
Chronic Obstructive Pulmonary Disease (COPD)
Duloxetine
Major Depressive Disorder
Olaparib 300mg tablets
Newly Diagnosed
MEDI4736 (Durvalumab)+Tremelimumab
Non-Small-Cell Lung Carcinoma NSCLC
Exemestane
Locally Advanced Breast Cancer
Symbicort Turbuhaler (Budesonide/formoterol)
Chronic Obstructive Pulmonary Disease
rosiglitazone
Diabetes Mellitus, Type 2
AZD0585
Hypertriglyceridemia
Gefitinib or Docetaxel
Non-Small Cell Lung Cancer
insulin glargine
Type 2 Diabetes Mellitus
Rosuvastatin
Aortic Stenosis
R-mini-CHOP
Large B-cell Lymphoma
HFA MDI
Asthma
Budesonide/formoterol pMDI 40/2.25ug + spacer
Asthma
MEDI4736
Ovarian
D961H sachet 10 mg
Gastric Ulcer (GU)
Esomeprazole
NSAIDs
Osimertinib
Non-Small Cell Lung Cancer
Esomeprazole (Nexium)
Gastroesophageal Reflux Disease (GERD)
Eribulin
Breast Cancer
Volrustomig
Unresectable Pleural Mesothelioma
Docetaxel
Non-Small-Cell Lung Carcinoma
AZD9291
Non-Small Cell Lung Cancer
Durvalumab +Tremelimumab
Non Small Cell Lung Carcinoma NSCLC
BFF MDI 160/9.6 μg BID (320/19.2μg/day)
Asthma
Durvalumab
Hepatocellular Carcinoma
Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Durvalumab + Chemotherapy phase
Advanced or Recurrent Endometrial Cancer
Anastozole (Arimidex)
Breast Cancer
pioglitazone
Type 2 Diabetes Mellitus
Prednisolone
Chronic Obstructive Pulmonary Disease
Exenatide Once Weekly
Type 2 Diabetes Mellitus
AZD9291 Dosing
Lung Cancer
insulin detemir
Type 2 Diabetes Mellitus
Gefitinib
NSCLC
Atorvastatin
Hypercholesterolaemia
Experimental: Tralokinumab
Uncontrolled Asthma
Nab-paclitaxel
Non-small Cell Lung Cancer
Cisplatin
Non-Small Cell Lung Cancer
Baxdrostat
Primary Hyperaldosteronism
Durvalumab (MEDI4736)
Non Small Cell Lung Carcinoma NSCLC
BGF MDI 320/14.4/9.6 μg
COPD (Chronic Obstructive Pulmonary Disease)
Salbutamol
COPD
olaparib
Colorectal Cancer
Dato-DXd
Metastatic Non-small Cell Lung Cancer
Benralizumab 30 mg SC + Mometasone Furoate
Nasal Polyposis
Sodium Zirconium Cyclosilicate 5g
Hyperkalemia
TC-5214
Major Depressive Disorder
Fluticasone propionate
Seasonal Allergic Rhinitis
Dapagliflozin
Type 2 Diabetes Mellitus
Capivasertib
Triple Negative Breast Neoplasms
Ciclesonide
Asthma
Open Label Run In Esomeprazole
Gastroesophageal Reflux Disease (GERD)
Datopotamab Deruxtecan
Non-Small Cell Lung Cancer
exenatide twice daily
Type 2 Diabetes Mellitus
Saxagliptin
Type 2 Diabetes
Metformin IR
Diabetes Mellitus, Type 2
NXY-059
Cerebral Stroke
Capecitabine
Breast Cancer
budesonide/formoterol (Symbicort)
Mild or Moderate Asthma
Metoprolol Succinate
High Blood Pressure (Hypertension).
Fulvestrant
Advanced Breast Cancer
Seroquel SR
Schizophrenia
Exenatide once weekly suspension
Diabetes Type 2
NKTR-118
Opioid-Induced Constipation (OIC)
Ciclesonide Nasal Spray
Rhinitis, Allergic, Seasonal
Tezepelumab
Asthma
Formoterol (OT)
Chronic Obstructive Pulmonary Disease
Nirsevimab
Lower Respiratory Tract Infection
Experimental: Tezepelumab
Asthma
formoterol
Stable Asthma
fluticasone/salmeterol
Asthma
Quetiapine Extended Release
Schizophrenia
Tremelimumab
Non Small Cell Lung Cancer NSCLC
enzalutamide
Metastatic Castration-resistant Prostate Cancer
Dapagliflozin 10 mg
Type 2 Diabetes Mellitus
Monalizumab
Squamous Cell Carcinoma of the Head and Neck
Ticagrelor 90 mg
Myocardial Infarction
Aclidinium bromide/formoterol Fixed-Dose Combination
COPD
Gemcitabine
Urothelial Cancer
Pravastatin
Hypercholesterolemia
Quetiapine SR
Anxiety Disorders
Benralizumab
Asthma
Omeprazole
Non-erosive Reflux Disease
Quetiapine
Psychotic Disorders
Terbutaline Turbuhaler
Asthma
exenatide
Type 2 Diabetes Mellitus
AC2993
Diabetes Mellitus, Non-Insulin-Dependent
Anifrolumab
Active Systemic Lupus Erythematosus
Lithium
Mania
BGF MDI 320/28.8/9.6 μg
Asthma
Simvastatin
Hypercholesterolemia
Lenvatinib
Hepatocellular Carcinoma
Etoposide
Non-small Cell Lung Cancer
Baxdrostat/dapagliflozin
Chronic Kidney Disease and Hypertension
fostamatinib
Rheumatoid Arthritis
Bicalutamide
Prostate Cancer
budesonide/formoterol
Asthma
Quetiapine fumarate
Schizophrenia
Budesonide Turbuhaler (Pulmicort)
Asthma
Pemetrexed
NSCLC
Paroxetine
Generalized Anxiety Disorder
Glyburide
Diabetes
Seloken ZOK/Toprol-XL
Heart Failure, Congestive
Quetiapine Fumarate (SEROQUEL) Extended Release
Bipolar Depression
Risperidone
Schizophrenia
Budesonide/formoterol (SYMBICORT) pMDI
Asthma
Esomeprazole 40 mg
Gastric Ulcer
Saruparib
Metastatic Castration-Sensitive Prostate Cancer
Symbicort, used twice daily (b.i.d) and as needed (prn)
Asthma
Camizestrant
Breast Cancer, Early Breast Cancer
budesonide
Asthma
Symbicort Turbuhaler
Asthma
Quetiapine XR
Schizophrenic Disorders
Tamoxifen
Bone Density
Erlotinib 150/100 mg
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
fluticasone
Asthma
AZD0901
Gastric Cancer
Paclitaxel
Metastatic Breast Cancer
Ramucirumab+ paclitaxel
Gastric Cancer
Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
Chronic Obstructive Pulmonary Disease
Candesartan
Congestive Heart Failure
Puxitatug Samrotecan
Endometrial Cancer
Ticagrelor
Peripheral Artery Disease
Symbicort pMDI
Asthma
Rosuvastatin calcium
Coronary Arteriosclerosis
pramlintide acetate
Overweight
BDA MDI HFO 160/180 μg
Asthma
Rilvegostomig
Biliary Tract Cancer
Budesonide/formoterol (Symbicort Turbuhaler)
Chronic Obstructive Pulmonary Disease
Selumetinib
Neurofibromatosis 1
Symbicort
Asthma
Anastrozole
Breast Neoplasms
Domvanalimab
Non-Small Cell Lung Cancer
75mg selumetinib
Metastatic
glimepiride
Type 2 Diabetes Mellitus
biphasic insulin aspart
Diabetes Mellitus, Type 2
AZD9833
Advanced ER-Positive HER2-Negative Breast Cancer
Letrozole
ER-Positive HER2-Negative Breast Cancer
Ranitidine
NSAID Associated Gastric Ulcers
AZD7442
COVID-19
Ropivacaine
Anesthesia,Spinal
Tralokinumab
Asthma
Chlorambucil
Untreated Chronic Lymphocytic Leukemia
Roflumilast
Asthma
Acalabrutinib
Phase I: Relapsed or Refractory B-cell Malignancies
Budesonide/formoterol Turbuhaler
Asthma
candesartan cilexetil
Type 1 Diabetes
dacarbazine
Melanoma
AZD9291 80 mg/40 mg
Stage IB-IIIA Non-small Cell Lung Carcinoma
AZD0780
Cardiovascular Disease
ARIMIDEX (anastrazole)
Breast Cancer
savolitinib
Carcinoma
MEDI4736 (Durvalumab)
Advanced Solid Malignancies
Terbutaline
Asthma
Sunitinib
Carcinoma
sitagliptin
Type 2 Diabetes
abiraterone acetate
Metastatic Castration-resistant Prostate Cancer
metformin
Type 2 Diabetes Mellitus
MEDI7183 low dose
Ulcerative Colitis
MEDI4736 + Tremelimumab
Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
Tomudex
Inoperable or Recurrent Rectal Cancer
AZD0837
Persistent or Permanent Non-valvular Atrial Fibrillation
AZD7798
Moderate to Severe Crohn's Disease
AZD7624 1.0 mg
Chronic Obstructive Pulmonary Disease COPD
Tesaglitazar
Type 2 Diabetes
ZD4054
Non Small Cell Lung Cancer
Aclidinium bromide and formoterol
Chronic Obstructive Pulmonary Disease (COPD)
Cediranib
Renal Cell Carcinoma
Selumetinib granule formulation
Neurofibromatosis Type 1
MEDI3506
Diabetic Kidney Disease
AZD4635
Progressive Metastatic Castrate-Resistant Prostate Cancer
Selumetinib+Docetaxel
Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)
CP-675,206
Carcinoma, Non-small-cell Lung
Febuxostat
Asymptomatic Hyperuricemia
AZD1386
Pain
FOLFOX
Gastric Cancer
AZD5213 + pregabalin
Diabetic Neuropathy, Painful; Diabetic Neuropathies
RDEA3170
Gout and Asymptomatic Hyperuricemia
AZD5863
Gastric Cancer
Ceralasertib
Advanced or Metastatic NSCLC
AZD3632
Acute Lymphoblastic Leukaemia
Adavosertib
Uterine Serous Carcinoma
AZD8233
Dyslipidaemia
AZD4144
Sepsis
AZD0516
Metastatic Prostate Cancer
Acalabrutinib monotherapy
Mantle-cell Lymphoma
MEDI4736 in combination with nab-paclitaxel and gemcitabine
Metastatic Pancreatic Ductal Adenocarcinoma
AZD6234
Endocrinology
Datopotamab Deruxtecan (Dato-DXd)
Carcinoma, Non-Small-Cell Lung
exenatide once monthly suspension
Type 2 Diabetes
Amivantamab
Non-Small Cell Lung Cancer (NSCLC)
Zibotentan
Chronic Kidney Disease
Venetoclax
Mantle Cell Lymphoma (MCL)
AZD5672
Rheumatoid Arthritis
AZD2281
Ovarian Carcinoma
Zibotentan + dapagliflozin
Liver Cirrhosis
tralokinumab cohort 1
Idiopathic Pulmonary Fibrosis
Anastrazole
Breast Cancer
AZD2811
Small-Cell Lung Cancer
AZD6793
Chronic Obstructive Pulmonary Disease (COPD)
AZD7268
Major Depressive Disorder
Quetiapine fumarate (Seroquel)
Major Depressive Disorder
AZD5305
Metastatic Prostate Cancer
AZD1236
Chronic Obstructive Pulmonary Disease
AZD3480
Alzheimer Disease
AZD0292
Bronchiectasis With Pseudomonas Aeruginosa Colonization
AZD6765
Depression
AZD9550
Obesity or Overweight
AZD4547
FGFR Inhibition, Pharmacokinetics, Biomarkers
AZD5423
Asthma
AZD1446
Mild to Moderate Alzheimer's Disease
AZD3470
Advanced Solid Tumors That Are MTAP Deficient
AZD5148
Clostridioides Difficile Infection
CIN-107
Hypertension
AZD1981
Chronic Obstructive Pulmonary Disease
AZD7325
Anxiety Disorders
Oleclumab
Non-Small Cell Lung Cancer
AZD8848
Allergic Rhinitis
Drug: carboplatin
Ovarian Cancer
ZD4054 15 mg
Prostate Cancer
Hydrochlorothiazide
Type 2 Diabetes Mellitus
Verinurad
Heart Failure With Preserved Ejection Fraction (HFpEF)
MEDI0382 100 μg
Type 2 Diabetes
AZD3199
Asthma
AZD5004
Obesity or Overweight
AZD2171
Gastrointestinal Stromal Tumors
Zibotentan/Dapagliflozin
Chronic Kidney Disease With High Proteinuria
Glipizide
Type II Diabetes Mellitus
AZD6244
Metastatic Colorectal Cancer
AZD5069
Bronchiectasis
Goserelin acetate
Breast Cancer
AZD1305
Left Ventricle Function
AZD3355
Reflux Episodes
AZD4831
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
MEDI-546
Systemic Lupus Erythematosus
AZD4604
Asthma
Ciclesonide HFA
Rhinitis, Allergic, Seasonal
AZD4877
Bladder Cancer
AZD9773
Severe Sepsis
AZD0305
Multiple Myeloma
AZD1656
Type II Diabetes
AZD9567
Rheumatoid Arthritis
Gefitinib 250mg
Lung Cancer
AZD2423
Chronic Obstructive Pulmonary Disease
AZD2066
Pain
AZD4573
Relapsed/Refractory Peripheral T-cell Lymphoma
[18F]AZD4694
Alzheimer's Disease
CP-675,206 (Tremelimumab)
Colorectal Neoplasms
AZD1222
COVID-19
AZD9668
Chronic Obstructive Pulmonary Disease (COPD)
CIN-107 2 mg dosing
Primary Aldosteronism
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
budesonide (Pulmicort) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
SEROQUEL (quetiapine fumarate) Tablets | Phase 3 | Bipolar Disorder | - | - |
Carboplatin | Phase 3 | Endometrial Cancer | - | - |
Tozorakimab | Phase 3 | Asthma | - | - |
Taxane | Phase 3 | Breast Cancer; HER2-positive; Metastatic | - | - |
Metformin XR | Phase 3 | Type 2 Diabetes | - | - |
AZD0486 | Phase 3 | B-cell Acute Lymphoblastic Leukemia (B-ALL) | - | - |
methotrexate | Phase 3 | Squamous Cell Carcinoma of the Head and Neck | - | - |
Rosuvastatin 20mg | Phase 3 | Homozygous Familial Hypercholesterolemia (HoFH) | - | - |
Aclidinium bromide | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Aclidinium Bromide/Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Duloxetine | Phase 3 | Major Depressive Disorder | - | - |
Olaparib 300mg tablets | Phase 3 | Newly Diagnosed | - | - |
MEDI4736 (Durvalumab)+Tremelimumab | Phase 3 | Non-Small-Cell Lung Carcinoma NSCLC | - | - |
Exemestane | Phase 3 | Locally Advanced Breast Cancer | - | - |
Symbicort Turbuhaler (Budesonide/formoterol) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
rosiglitazone | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
AZD0585 | Phase 3 | Hypertriglyceridemia | - | - |
Gefitinib or Docetaxel | Phase 3 | Non-Small Cell Lung Cancer | - | - |
insulin glargine | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Rosuvastatin | Phase 3 | Aortic Stenosis | - | - |
R-mini-CHOP | Phase 3 | Large B-cell Lymphoma | - | - |
HFA MDI | Phase 3 | Asthma | - | - |
Budesonide/formoterol pMDI 40/2.25ug + spacer | Phase 3 | Asthma | - | - |
MEDI4736 | Phase 3 | Ovarian | - | - |
D961H sachet 10 mg | Phase 3 | Gastric Ulcer (GU) | - | - |
Esomeprazole | Phase 3 | NSAIDs | - | - |
Osimertinib | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Esomeprazole (Nexium) | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
Eribulin | Phase 3 | Breast Cancer | - | - |
Volrustomig | Phase 3 | Unresectable Pleural Mesothelioma | - | - |
Docetaxel | Phase 3 | Non-Small-Cell Lung Carcinoma | - | - |
AZD9291 | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Durvalumab +Tremelimumab | Phase 3 | Non Small Cell Lung Carcinoma NSCLC | - | - |
BFF MDI 160/9.6 μg BID (320/19.2μg/day) | Phase 3 | Asthma | - | - |
Durvalumab | Phase 3 | Hepatocellular Carcinoma | - | - |
Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Durvalumab + Chemotherapy phase | Phase 3 | Advanced or Recurrent Endometrial Cancer | - | - |
Anastozole (Arimidex) | Phase 3 | Breast Cancer | - | - |
pioglitazone | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Prednisolone | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Exenatide Once Weekly | Phase 3 | Type 2 Diabetes Mellitus | - | - |
AZD9291 Dosing | Phase 3 | Lung Cancer | - | - |
insulin detemir | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Gefitinib | Phase 3 | NSCLC | - | - |
Atorvastatin | Phase 3 | Hypercholesterolaemia | - | - |
Experimental: Tralokinumab | Phase 3 | Uncontrolled Asthma | - | - |
Nab-paclitaxel | Phase 3 | Non-small Cell Lung Cancer | - | - |
Cisplatin | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Baxdrostat | Phase 3 | Primary Hyperaldosteronism | - | - |
Durvalumab (MEDI4736) | Phase 3 | Non Small Cell Lung Carcinoma NSCLC | - | - |
BGF MDI 320/14.4/9.6 μg | Phase 3 | COPD (Chronic Obstructive Pulmonary Disease) | - | - |
Salbutamol | Phase 3 | COPD | - | - |
olaparib | Phase 3 | Colorectal Cancer | - | - |
Dato-DXd | Phase 3 | Metastatic Non-small Cell Lung Cancer | - | - |
Benralizumab 30 mg SC + Mometasone Furoate | Phase 3 | Nasal Polyposis | - | - |
Sodium Zirconium Cyclosilicate 5g | Phase 3 | Hyperkalemia | - | - |
TC-5214 | Phase 3 | Major Depressive Disorder | - | - |
Fluticasone propionate | Phase 3 | Seasonal Allergic Rhinitis | - | - |
Dapagliflozin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Capivasertib | Phase 3 | Triple Negative Breast Neoplasms | - | - |
Ciclesonide | Phase 3 | Asthma | - | - |
Open Label Run In Esomeprazole | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
Datopotamab Deruxtecan | Phase 3 | Non-Small Cell Lung Cancer | - | - |
exenatide twice daily | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Saxagliptin | Phase 3 | Type 2 Diabetes | - | - |
Metformin IR | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
NXY-059 | Phase 3 | Cerebral Stroke | - | - |
Capecitabine | Phase 3 | Breast Cancer | - | - |
budesonide/formoterol (Symbicort) | Phase 3 | Mild or Moderate Asthma | - | - |
Metoprolol Succinate | Phase 3 | High Blood Pressure (Hypertension). | - | - |
Fulvestrant | Phase 3 | Advanced Breast Cancer | - | - |
Seroquel SR | Phase 3 | Schizophrenia | - | - |
Exenatide once weekly suspension | Phase 3 | Diabetes Type 2 | - | - |
NKTR-118 | Phase 3 | Opioid-Induced Constipation (OIC) | - | - |
Ciclesonide Nasal Spray | Phase 3 | Rhinitis, Allergic, Seasonal | - | - |
Tezepelumab | Phase 3 | Asthma | - | - |
Formoterol (OT) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Nirsevimab | Phase 3 | Lower Respiratory Tract Infection | - | - |
Experimental: Tezepelumab | Phase 3 | Asthma | - | - |
formoterol | Phase 3 | Stable Asthma | - | - |
fluticasone/salmeterol | Phase 3 | Asthma | - | - |
Quetiapine Extended Release | Phase 3 | Schizophrenia | - | - |
Tremelimumab | Phase 3 | Non Small Cell Lung Cancer NSCLC | - | - |
enzalutamide | Phase 3 | Metastatic Castration-resistant Prostate Cancer | - | - |
Dapagliflozin 10 mg | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Monalizumab | Phase 3 | Squamous Cell Carcinoma of the Head and Neck | - | - |
Ticagrelor 90 mg | Phase 3 | Myocardial Infarction | - | - |
Aclidinium bromide/formoterol Fixed-Dose Combination | Phase 3 | COPD | - | - |
Gemcitabine | Phase 3 | Urothelial Cancer | - | - |
Pravastatin | Phase 3 | Hypercholesterolemia | - | - |
Quetiapine SR | Phase 3 | Anxiety Disorders | - | - |
Benralizumab | Phase 3 | Asthma | - | - |
Omeprazole | Phase 3 | Non-erosive Reflux Disease | - | - |
Quetiapine | Phase 3 | Psychotic Disorders | - | - |
Terbutaline Turbuhaler | Phase 3 | Asthma | - | - |
exenatide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
AC2993 | Phase 3 | Diabetes Mellitus, Non-Insulin-Dependent | - | - |
Anifrolumab | Phase 3 | Active Systemic Lupus Erythematosus | - | - |
Lithium | Phase 3 | Mania | - | - |
BGF MDI 320/28.8/9.6 μg | Phase 3 | Asthma | - | - |
Simvastatin | Phase 3 | Hypercholesterolemia | - | - |
Lenvatinib | Phase 3 | Hepatocellular Carcinoma | - | - |
Etoposide | Phase 3 | Non-small Cell Lung Cancer | - | - |
Baxdrostat/dapagliflozin | Phase 3 | Chronic Kidney Disease and Hypertension | - | - |
fostamatinib | Phase 3 | Rheumatoid Arthritis | - | - |
Bicalutamide | Phase 3 | Prostate Cancer | - | - |
budesonide/formoterol | Phase 3 | Asthma | - | - |
Quetiapine fumarate | Phase 3 | Schizophrenia | - | - |
Budesonide Turbuhaler (Pulmicort) | Phase 3 | Asthma | - | - |
Pemetrexed | Phase 3 | NSCLC | - | - |
Paroxetine | Phase 3 | Generalized Anxiety Disorder | - | - |
Glyburide | Phase 3 | Diabetes | - | - |
Seloken ZOK/Toprol-XL | Phase 3 | Heart Failure, Congestive | - | - |
Quetiapine Fumarate (SEROQUEL) Extended Release | Phase 3 | Bipolar Depression | - | - |
Risperidone | Phase 3 | Schizophrenia | - | - |
Budesonide/formoterol (SYMBICORT) pMDI | Phase 3 | Asthma | - | - |
Esomeprazole 40 mg | Phase 3 | Gastric Ulcer | - | - |
Saruparib | Phase 3 | Metastatic Castration-Sensitive Prostate Cancer | - | - |
Symbicort, used twice daily (b.i.d) and as needed (prn) | Phase 3 | Asthma | - | - |
Camizestrant | Phase 3 | Breast Cancer, Early Breast Cancer | - | - |
budesonide | Phase 3 | Asthma | - | - |
Symbicort Turbuhaler | Phase 3 | Asthma | - | - |
Quetiapine XR | Phase 3 | Schizophrenic Disorders | - | - |
Tamoxifen | Phase 3 | Bone Density | - | - |
Erlotinib 150/100 mg | Phase 3 | Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer | - | - |
fluticasone | Phase 3 | Asthma | - | - |
AZD0901 | Phase 3 | Gastric Cancer | - | - |
Paclitaxel | Phase 3 | Metastatic Breast Cancer | - | - |
Ramucirumab+ paclitaxel | Phase 3 | Gastric Cancer | - | - |
Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Candesartan | Phase 3 | Congestive Heart Failure | - | - |
Puxitatug Samrotecan | Phase 3 | Endometrial Cancer | - | - |
Ticagrelor | Phase 3 | Peripheral Artery Disease | - | - |
Symbicort pMDI | Phase 3 | Asthma | - | - |
Rosuvastatin calcium | Phase 3 | Coronary Arteriosclerosis | - | - |
pramlintide acetate | Phase 3 | Overweight | - | - |
BDA MDI HFO 160/180 μg | Phase 3 | Asthma | - | - |
Rilvegostomig | Phase 3 | Biliary Tract Cancer | - | - |
Budesonide/formoterol (Symbicort Turbuhaler) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Selumetinib | Phase 3 | Neurofibromatosis 1 | - | - |
Symbicort | Phase 3 | Asthma | - | - |
Anastrozole | Phase 3 | Breast Neoplasms | - | - |
Domvanalimab | Phase 3 | Non-Small Cell Lung Cancer | - | - |
75mg selumetinib | Phase 3 | Metastatic | - | - |
glimepiride | Phase 3 | Type 2 Diabetes Mellitus | - | - |
biphasic insulin aspart | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
AZD9833 | Phase 3 | Advanced ER-Positive HER2-Negative Breast Cancer | - | - |
Letrozole | Phase 3 | ER-Positive HER2-Negative Breast Cancer | - | - |
Ranitidine | Phase 3 | NSAID Associated Gastric Ulcers | - | - |
AZD7442 | Phase 3 | COVID-19 | - | - |
Ropivacaine | Phase 3 | Anesthesia,Spinal | - | - |
Tralokinumab | Phase 3 | Asthma | - | - |
Chlorambucil | Phase 3 | Untreated Chronic Lymphocytic Leukemia | - | - |
Roflumilast | Phase 3 | Asthma | - | - |
Acalabrutinib | Phase 3 | Phase I: Relapsed or Refractory B-cell Malignancies | - | - |
Budesonide/formoterol Turbuhaler | Phase 3 | Asthma | - | - |
candesartan cilexetil | Phase 3 | Type 1 Diabetes | - | - |
dacarbazine | Phase 3 | Melanoma | - | - |
AZD9291 80 mg/40 mg | Phase 3 | Stage IB-IIIA Non-small Cell Lung Carcinoma | - | - |
AZD0780 | Phase 3 | Cardiovascular Disease | - | - |
ARIMIDEX (anastrazole) | Phase 3 | Breast Cancer | - | - |
savolitinib | Phase 3 | Carcinoma | - | - |
MEDI4736 (Durvalumab) | Phase 3 | Advanced Solid Malignancies | - | - |
Terbutaline | Phase 3 | Asthma | - | - |
Sunitinib | Phase 3 | Carcinoma | - | - |
sitagliptin | Phase 3 | Type 2 Diabetes | - | - |
abiraterone acetate | Phase 3 | Metastatic Castration-resistant Prostate Cancer | - | - |
metformin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
MEDI7183 low dose | Phase 2 | Ulcerative Colitis | - | - |
MEDI4736 + Tremelimumab | Phase 2 | Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck | - | - |
Tomudex | Phase 2 | Inoperable or Recurrent Rectal Cancer | - | - |
AZD0837 | Phase 2 | Persistent or Permanent Non-valvular Atrial Fibrillation | - | - |
AZD7798 | Phase 2 | Moderate to Severe Crohn's Disease | - | - |
AZD7624 1.0 mg | Phase 2 | Chronic Obstructive Pulmonary Disease COPD | - | - |
Tesaglitazar | Phase 2 | Type 2 Diabetes | - | - |
ZD4054 | Phase 2 | Non Small Cell Lung Cancer | - | - |
Aclidinium bromide and formoterol | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Cediranib | Phase 2 | Renal Cell Carcinoma | - | - |
Selumetinib granule formulation | Phase 2 | Neurofibromatosis Type 1 | - | - |
MEDI3506 | Phase 2 | Diabetic Kidney Disease | - | - |
AZD4635 | Phase 2 | Progressive Metastatic Castrate-Resistant Prostate Cancer | - | - |
Selumetinib+Docetaxel | Phase 2 | Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) | - | - |
CP-675,206 | Phase 2 | Carcinoma, Non-small-cell Lung | - | - |
Febuxostat | Phase 2 | Asymptomatic Hyperuricemia | - | - |
AZD1386 | Phase 2 | Pain | - | - |
FOLFOX | Phase 2 | Gastric Cancer | - | - |
AZD5213 + pregabalin | Phase 2 | Diabetic Neuropathy, Painful; Diabetic Neuropathies | - | - |
RDEA3170 | Phase 2 | Gout and Asymptomatic Hyperuricemia | - | - |
AZD5863 | Phase 2 | Gastric Cancer | - | - |
Ceralasertib | Phase 2 | Advanced or Metastatic NSCLC | - | - |
AZD3632 | Phase 2 | Acute Lymphoblastic Leukaemia | - | - |
Adavosertib | Phase 2 | Uterine Serous Carcinoma | - | - |
AZD8233 | Phase 2 | Dyslipidaemia | - | - |
AZD4144 | Phase 2 | Sepsis | - | - |
AZD0516 | Phase 2 | Metastatic Prostate Cancer | - | - |
Acalabrutinib monotherapy | Phase 2 | Mantle-cell Lymphoma | - | - |
MEDI4736 in combination with nab-paclitaxel and gemcitabine | Phase 2 | Metastatic Pancreatic Ductal Adenocarcinoma | - | - |
AZD6234 | Phase 2 | Endocrinology | - | - |
Datopotamab Deruxtecan (Dato-DXd) | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
exenatide once monthly suspension | Phase 2 | Type 2 Diabetes | - | - |
Amivantamab | Phase 2 | Non-Small Cell Lung Cancer (NSCLC) | - | - |
Zibotentan | Phase 2 | Chronic Kidney Disease | - | - |
Venetoclax | Phase 2 | Mantle Cell Lymphoma (MCL) | - | - |
AZD5672 | Phase 2 | Rheumatoid Arthritis | - | - |
AZD2281 | Phase 2 | Ovarian Carcinoma | - | - |
Zibotentan + dapagliflozin | Phase 2 | Liver Cirrhosis | - | - |
tralokinumab cohort 1 | Phase 2 | Idiopathic Pulmonary Fibrosis | - | - |
Anastrazole | Phase 2 | Breast Cancer | - | - |
AZD2811 | Phase 2 | Small-Cell Lung Cancer | - | - |
AZD6793 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD7268 | Phase 2 | Major Depressive Disorder | - | - |
Quetiapine fumarate (Seroquel) | Phase 2 | Major Depressive Disorder | - | - |
AZD5305 | Phase 2 | Metastatic Prostate Cancer | - | - |
AZD1236 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD3480 | Phase 2 | Alzheimer Disease | - | - |
AZD0292 | Phase 2 | Bronchiectasis With Pseudomonas Aeruginosa Colonization | - | - |
AZD6765 | Phase 2 | Depression | - | - |
AZD9550 | Phase 2 | Obesity or Overweight | - | - |
AZD4547 | Phase 2 | FGFR Inhibition, Pharmacokinetics, Biomarkers | - | - |
AZD5423 | Phase 2 | Asthma | - | - |
AZD1446 | Phase 2 | Mild to Moderate Alzheimer's Disease | - | - |
AZD3470 | Phase 2 | Advanced Solid Tumors That Are MTAP Deficient | - | - |
AZD5148 | Phase 2 | Clostridioides Difficile Infection | - | - |
CIN-107 | Phase 2 | Hypertension | - | - |
AZD1981 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD7325 | Phase 2 | Anxiety Disorders | - | - |
Oleclumab | Phase 2 | Non-Small Cell Lung Cancer | - | - |
AZD8848 | Phase 2 | Allergic Rhinitis | - | - |
Drug: carboplatin | Phase 2 | Ovarian Cancer | - | - |
ZD4054 15 mg | Phase 2 | Prostate Cancer | - | - |
Hydrochlorothiazide | Phase 2 | Type 2 Diabetes Mellitus | - | - |
Verinurad | Phase 2 | Heart Failure With Preserved Ejection Fraction (HFpEF) | - | - |
MEDI0382 100 μg | Phase 2 | Type 2 Diabetes | - | - |
AZD3199 | Phase 2 | Asthma | - | - |
AZD5004 | Phase 2 | Obesity or Overweight | - | - |
AZD2171 | Phase 2 | Gastrointestinal Stromal Tumors | - | - |
Zibotentan/Dapagliflozin | Phase 2 | Chronic Kidney Disease With High Proteinuria | - | - |
Glipizide | Phase 2 | Type II Diabetes Mellitus | - | - |
AZD6244 | Phase 2 | Metastatic Colorectal Cancer | - | - |
AZD5069 | Phase 2 | Bronchiectasis | - | - |
Goserelin acetate | Phase 2 | Breast Cancer | - | - |
AZD1305 | Phase 2 | Left Ventricle Function | - | - |
AZD3355 | Phase 2 | Reflux Episodes | - | - |
AZD4831 | Phase 2 | Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis | - | - |
MEDI-546 | Phase 2 | Systemic Lupus Erythematosus | - | - |
AZD4604 | Phase 2 | Asthma | - | - |
Ciclesonide HFA | Phase 2 | Rhinitis, Allergic, Seasonal | - | - |
AZD4877 | Phase 2 | Bladder Cancer | - | - |
AZD9773 | Phase 2 | Severe Sepsis | - | - |
AZD0305 | Phase 2 | Multiple Myeloma | - | - |
AZD1656 | Phase 2 | Type II Diabetes | - | - |
AZD9567 | Phase 2 | Rheumatoid Arthritis | - | - |
Gefitinib 250mg | Phase 2 | Lung Cancer | - | - |
AZD2423 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD2066 | Phase 2 | Pain | - | - |
AZD4573 | Phase 2 | Relapsed/Refractory Peripheral T-cell Lymphoma | - | - |
[18F]AZD4694 | Phase 2 | Alzheimer's Disease | - | - |
CP-675,206 (Tremelimumab) | Phase 2 | Colorectal Neoplasms | - | - |
AZD1222 | Phase 2 | COVID-19 | - | - |
AZD9668 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
CIN-107 2 mg dosing | Phase 2 | Primary Aldosteronism | - | - |